Article Versions Notes

Liu L, Schuetze R, Gerberich JL, Lopez R, Odutola SO, Tanpure RP, Charlton-Sevcik AK, Tidmore JK, Taylor EA-S, Kapur P, et al. Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment. Cancers. 2022; 14(17):4208. https://doi.org/10.3390/cancers14174208

Liu, Li, Regan Schuetze, Jeni L. Gerberich, Ramona Lopez, Samuel O. Odutola, Rajendra P. Tanpure, Amanda K. Charlton-Sevcik, Justin K. Tidmore, Emily A.-S. Taylor, Payal Kapur, and et al. 2022. "Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment" Cancers 14, no. 17: 4208. https://doi.org/10.3390/cancers14174208

Liu, L., Schuetze, R., Gerberich, J. L., Lopez, R., Odutola, S. O., Tanpure, R. P., Charlton-Sevcik, A. K., Tidmore, J. K., Taylor, E. A.-S., Kapur, P., Hammers, H., Trawick, M. L., Pinney, K. G., & Mason, R. P. (2022). Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment. Cancers, 14(17), 4208. https://doi.org/10.3390/cancers14174208